510(k) Report

FDA product code · Anesthesiology

Cannula, Nasal, Oxygen

CATClass I21 CFR 868.5340510(k) exempt42 decisions since 19765 recalls

FDA lists CAT as exempt from 510(k): a device of this type needs no clearance unless one of the limits in 21 CFR 868.9 applies, such as a new intended use or a different fundamental technology. 42 FDA decisions since 1976. 5 recalls name this code, 0 of them Class I. The most-cited predicate is K011125, named by 1 later device.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, anesthesiology panel

Twenty years of CAT at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · CAT

FDA has decided no CAT device since 2007.

Median 510(k) review, days · CAT

Too few CAT 510(k)s in any year since 2007 to give a median.

Recalls per year · CAT

5in 2018

2018: 5
2007high 5 (2018) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CAT

79in 2025

2007: 82008: 122009: 192010: 442011: 332012: 502013: 1182014: 1472015: 1092016: 1742017: 1282018: 912019: 1052020: 1352021: 1282022: 742023: 1162024: 752025: 79
2007high 174 (2016) · low 8 (2007)2025

MAUDE reports naming product code CAT, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—08
20080—012
20090—019
20100—044
20110—033
20120—050
20130—0118
20140—0147
20150—0109
20160—0174
20170—0128
20180—591
20190—0105
20200—0135
20210—0128
20220—074
20230—0116
20240—075
20250—079
20260—0—
FIG. 1 — CAT by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in CAT? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report